Ready To Meet Your Complex OSD Needs, Seamlessly And Simply

Finding a CDMO partner with years of experience in successfully delivering high-quality OSD products — including highly potent, cytotoxic, controlled, and immunosuppressant drugs — can help avoid unnecessary costs and simplify your pathway to commercialization. CDMOs can help you navigate the path to market for complex OSD projects with the infrastructure necessary to help support development and manufacturing for clinical trials through launch and lifecycle management.

Pfizer CentreOne’s right first time approach accelerates your project through key milestones with a robust technology transfer process that ensures a fast start and process analytical technology that helps increase efficiency and reduce cost.